1 not yet recruiting, 1 unknown. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Qiong Fu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GC012F in Patients With Autoimmune Diseases GC012F injection - Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathy (IIM) | Early Phase 1 | Not yet recruiting | Qiong Fu | 15 | 2025-08-18 | 2025-07-18 |
| A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus Sulfasalazine Tablets - Systemic Lupus Erythematosus | Phase 2 | Unknown | Qiong Fu | 20 | 2024-05-06 | 2024-04-11 |
Lupus Erythematosus, Systemic (1) · Myositis (1) · Scleroderma, Systemic (1)
Sulfasalazine (1)